Vaccination of healthcare personnel in Europe: Update to current policies.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
10 12 2019
Historique:
received: 04 01 2019
revised: 17 09 2019
accepted: 18 09 2019
pubmed: 19 10 2019
medline: 9 10 2020
entrez: 19 10 2019
Statut: ppublish

Résumé

We investigated and compared current national vaccination policies for health-care personnel (HCP) in Europe with results from our previous survey. Data from 36 European countries were collected using the same methodology as in 2011. National policies for HCP immunization were in place in all countries. There were significant differences in terms of number of vaccinations, target HCP and healthcare settings, and implementation regulations (recommended or mandatory vaccinations). Vaccination policies against hepatitis B and seasonal influenza were present in 35 countries each. Policies for vaccination of HCP against measles, mumps, rubella and varicella existed in 28, 24, 25 and 19 countries, respectively; and against tetanus, diphtheria, pertussis and poliomyelitis in 21, 20, 19, and 18 countries, respectively. Recommendations for hepatitis A immunization existed in 17 countries, and against meningococcus B, meningococcus C, meningococcus A, C, W, Y, and tuberculosis in 10, 8, 17, and 7 countries, respectively. Mandatory vaccination policies were found in 13 countries and were a pre-requisite for employment in ten. Comparing the vaccination programs of the 30 European countries that participated in the 2011 survey, we found that more countries had national vaccination policies against measles, mumps, rubella, hepatitis A, diphtheria, tetanus, poliomyelitis, pertussis, meningococcus C and/or meningococcus A, C, W, Y; and more of these implemented mandatory vaccination policies for HCP. In conclusion, European countries now have more comprehensive national vaccination programs for HCP, however there are still gaps. Given the recent large outbreaks of vaccine-preventable diseases in Europe and the occupational risk for HCP, vaccination policies need to be expanded and strengthened in several European countries. Overall, vaccination policies for HCP in Europe should be periodically re-evaluated in order to provide optimal protection against vaccine-preventable diseases and infection control within healthcare facilities for HCP and patients.

Identifiants

pubmed: 31623916
pii: S0264-410X(19)31285-X
doi: 10.1016/j.vaccine.2019.09.061
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7576-7584

Investigateurs

Silvia Bino (S)
Ursula Wiedermann (U)
Pierre Van Damme (P)
Radosveta Filipova (R)
Vladimir Draženović (V)
Maria Koliou (M)
Katerina Fabianova (K)
Jan Kyncl (J)
Lise Heilmann Jensen (L)
Irina Filippova (I)
Ulpu Elonsalo (U)
Elisabeth Botelho-Nevers (E)
Sabine Wicker (S)
Helena C Maltezou (HC)
Maria Theodoridou (M)
Zsuzsanna Molnár (Z)
Kamilla Sigridur Josefsdottir (K)
Lynda Sisson (L)
Caterina Ledda (C)
Jurijs Perevoscikovs (J)
Larisa Savrasova (L)
Saulius Caplinskas (S)
Françoise Berthet (F)
Judith M Hübschen (JM)
Michael Borg (M)
Olga Cirstea (O)
Gerrit A van Essen (GAV)
Arne B Brantsæter (AB)
Aneta Nitsch-Osuch (A)
Silva Graça (S)
Oana Falup-Pecurariu (O)
Irina Mikheeva (I)
Snežana Medić (S)
Dagmar Kollárová (D)
Tatjana Mrvic (T)
Raúl Ortiz de Lejarazu (RO)
Rose-Marie Carlsson (RM)
Adam Roth (A)
Ulrich Heininger (U)
Liudmyla Chernyshova (L)
Fedir Lapiy (F)
George Kassianos (G)
Gregory A Poland (GA)

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Helena C Maltezou (HC)

Department for Interventions in Health Care Facilities, Hellenic Centre for Disease Control and Prevention, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.

Elisabeth Botelho-Nevers (E)

Clinical Trial Center, INSERM CICEC 1408, and Infectious Diseases Department, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France.

Arne B Brantsæter (AB)

Department of Infectious Diseases and Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.

Rose-Marie Carlsson (RM)

Public Health Agency of Sweden, Solna, Sweden.

Ulrich Heininger (U)

University of Basel Children's Hospital, Basel, Switzerland.

Judith M Hübschen (JM)

Luxembourg Institute of Health, Luxembourg, Luxembourg.

Kamilla S Josefsdottir (KS)

Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland.

George Kassianos (G)

Royal College of General Practitioners, Wokingham, United Kingdom.

Jan Kyncl (J)

Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

Caterina Ledda (C)

Occupational Medicine, Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Snežana Medić (S)

Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia; Centre for Disease Control and Prevention, Institute of Public Health of Vojvodina, Novi Sad, Serbia.

Aneta Nitsch-Osuch (A)

Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland.

Raul Ortiz de Lejarazu (RO)

National Influenza Centre, School of Medicine, Microbiology and Immunology Department, Hospital Clinico Universitario, Valladolid, Spain.

Maria Theodoridou (M)

Aghia Sophia Children's Hospital, First Department of Pediatrics, University of Athens, Athens, Greece.

Pierre Van Damme (P)

Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Gerrit A van Essen (GA)

General Practitioner, Amersfoort, the Netherlands.

Sabine Wicker (S)

Occupational Health Service, University Hospital Frankfurt, Frankfurt am Main, Germany.

Ursula Wiedermann (U)

Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Vienna, Austria.

Gregory A Poland (GA)

Director, Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH